Request a Genetics in Clinical Trials training sessionWhat You'll Learn
Most Recent Flipbooks
Adverse Event Reporting: When TMI is Risky
Optimizing Global Safety Reporting in Clinical Trials
CNS Drugs Take Longer to Develop, Win Approval
Master Protocols Can Kickstart Clinical Trials
WCG, Inspire Team Up to Boost Trial Access
Are Scientists Closing in on Treatments for Schizophrenia's Most Elusive Symptoms?
IRBs can make the most of central IRB partnerships
The IRB at Inova Health System of Falls Church, VA, began working with a central IRB 15 years ago. Since then, the IRB developed a well-organized process for its partnerships with independent IRBs.
Navigation Through Fair Market Value Ambiguity
Conquer Study Start-Up Delays With a Data-Driven Approach
A new approach to solving start-up delays is built on this foundation of advanced data analytics and accelerates study start-up timelines by 33 percent.
FDA Posts First List of Surrogate Endpoints
Genetics in Precision Medicine: A Data Management Issue
Finding Good Sites in Today’s Competitive Site Landscape
Improving Clinical Site Payment Practices
IRBs and IBCs: Critical Partners in Gene Research
Improving Subject Selection and Endpoint Management in Alzheimer's Trials
DMC Regulations May Change, but Principles Won't
InformedDNA & WCG Partner to Fill Growing Need for Genetics Expertise in Clinical Trial Management
eCOA: Keep it Simple, Exec Argues
Safety Reporting: It Can Enter the 21st Century, If We Let It
FDA Proposes Three New Guidelines for Gene Therapy Trials